RecruitingNot ApplicableNCT06993922
Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy
Sponsor
Ain Shams University
Enrollment
50 participants
Start Date
May 29, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This study aims to compare dexmedetomidine as an adjuvant to bupivacaine in scalp block versus bupivacaine alone for postoperative pain management in patients undergoing craniotomy.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria4
- Age from 18 to 65 years.
- Both sexes.
- American Society of Anesthesiologists (ASA) physical status I or II.
- Undergoing supratentorial elective planned craniotomies.
Exclusion Criteria7
- Patients refusal.
- History of known allergy to the used local anesthetic or dexmedetomidine.
- Bleeding disorders.
- Evidence of local infection at the site of injection.
- Emergency craniotomy.
- Psychotic disorder.
- Patients who will not be extubated in the operating room after surgery.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERScalp block
Patients will receive a scalp block with bupivacaine alone.
OTHERScalp block + Dexmedetomidine
Patients will receive a scalp block with dexmedetomidine as an adjuvant to bupivacaine.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06993922
Related Trials
Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardiac Surgery
NCT075882301 location
Serratus Posterior Superior Intercostal Plane Block in Port Catheter Implantation
NCT075795721 location
Multimodal Fascial Plane Block for Postoperative Analgesia in Isolated CABG Surgery
NCT075873201 location
Efficacy of Liposomal Bupivacaine for Transversus Abdominis Plane Block
NCT075779341 location
Regional Analgesia Techniques for Laparoscopic Cholecystectomy
NCT072419491 location